21 May 2013
Keywords: alcon, withdraws, eu, retaane, maa, texas, usa-based
Article | 13 March 2006
Texas, USA-based Alcon has announced the withdrawal of its European marketing authorization application for Retaane (anecortave acetate
suspension for depot ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 March 2006
20 March 2006
20 May 2013
© 2013 thepharmaletter.com